Drug

TTP-607

As of the edition of 20 October 2026, TTP-607 is a drug: stopped in 2012; acts on AURKA, AURKB and AURKC.

Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.

The drug

Status
Stopped, 2012
Kind
Unknown
Registered trials
1, 1 stopped early
Disease areas
Blood and lymph; Cancer; Immune system

US protection

No US approval on record.

With no US approval on record there are no listed US patents or exclusivities.

This is the US only.

Targets

GeneProteinUniProt
AURKAAurora kinase AO14965
AURKBAurora kinase BQ96GD4
AURKCAurora kinase CQ9UQB9

Registered trials

PhaseTrialsCompletedActiveStopped early
Phase 11001
All trials1